
31
ISSN: 2763-5724 / Vol. 05 - n 05 - ano 2025
characterized by the decline in intellectual capacity, severe enough to interfere with social and
professional activities of daily living, and may represent a clinical condition of a neurodegenerative
nature, depending on the disorder and state of consciousness or wakefulness, which can be caused by
the impairment of the central nervous system (BOTTINO, 2018). The term dementia comes from the
Latin, dementia (de+mentia), which means “absence of mind”. In the twentieth century, this concept
was modied by researchers, as what had been inherited from the eighteenth century associated the
term with an irreversible and terminal state.
AD is a progressive neurodegenerative disease, being the most prevalent dementia in
population-based clinical studies, with prevalence and incidence of 50 to 75% of cases (HERRERA
et al., 2002; NITRINI et al., 2004). Clinical manifestation that includes progressive deterioration of
intellectual abilities and cognitive decline. Most cases begin after 65 years of age (late), however, in
some younger individuals (early) at 25 years of age. Age and low education are important risk factors
for late onset. (HESTAD; KVEBERG; ENGEDAL, 2005).
Other risk factors for late onset are the presence of the e4 allele of the aposto gene, history of
head trauma with loss of consciousness, lack of control of cardio-vascular risk factors (hypertension,
diabetes mellitus, dyslipidemia), sedentary lifestyle, and low cognitive demand throughout life
(AMERICAN PSYCHIATRIC ASSOCIATION, 1995). Early-onset AD is usually associated with
genetic mutations, and is most commonly described and related to the gene responsible for the amyloid
precursor protein (app) on chromosome 21.
Regardless of the age of onset, neuropathological ndings in AD patients are very similar:
presence of neuritic (senile) plaques and neurobrillary tangles, along with neural loss, dystrophic
nutrients, and glucose on histological examination. AD involves, among several processes, the
progressive decline of cholinergic neurotransmission in some specic regions, such as the hippocampus
and cerebral cortex. As the dysfunction progresses, cholinergic dysfunction leads to reduced ability to
perform activities of daily living, impairments in attention, memory, and the appearance of mood and
behavior changes. (MAIA, 2012).